We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

Latest press releases

Global scientific community commits to sharing data on Zika Leading global health bodies including academic journals, NGOs, research funders and institutes, have committed to sharing data and results relevant to the current Zika crisis and future public health emergencies as rapidly and openly as possible. 10 February 2016
No Hib booster needed by vaccinated infants in Kenya Children living in Kenya are well protected from life-threatening infections – such as meningitis, sepsis and pneumonia - caused by the bacteria Haemophilus influenzae type b (Hib), by the existing three-dose vaccine regime. 5 Feburary 2016
States of Mind: Tracing the Edges of Consciousness opens at Wellcome Collection Wellcome Collection opens the second part of a year-long exploration into human consciousness on 4 February 2016. ‘States of Mind: Tracing the Edges of Consciousness’ examines the universal, yet mysterious, topic of conscious experience. This major exhibition brings together artists, psychologists, philosophers and neuroscientists to investigate the terrain between consciousness and unconsciousness and will feature historical material, objects, artworks and an evolving programme of contemporary art installations. 04 February 2016
30m fund to bring new life to science centres The Wellcome Trust and the Department for Business, Innovation and Skills (BIS) have partnered to deliver a £30 million fund to breathe new life into science centres across the UK.

States of Mind: A collection of literature, science, philosophy and art To accompany a major exhibition opening in February 2016, Wellcome Collection will publish 'States of Mind: Experiences at the Edge of Consciousness'. The book is a collection of literature, science and art delving into the mysteries of human consciousness and featuring a new introduction by Mark Haddon, author of The Curious Incident of the Dog in the Night-Time 27 January 2016
Ebola legacy lab will improve Sierra Leone's resilience to future epidemics Samples from the recently confirmed case of Ebola in Sierra Leone have been analysed at a new infectious diseases laboratory in the country, set up in the wake of the epidemic. The research, carried out by two local scientists recently trained in next-generation genome sequencing techniques, will provide vital information about the virus that will help international scientists to identify the potential source of the infection. 22 January 2016
Global business should contribute towards cost of preparing for pandemics Global business should play a critical role in making the world more resilient against disease outbreaks, contributing to the investment needed to strengthen health systems, respond to epidemics and develop new vaccines and drugs, the World Economic Forum annual meeting in Davos heard today.
21 January 2016
New independent review panel for clinical data sharing website appointed In its role as secretariat for clinicalstudydatarequest.com, the Wellcome Trust has appointed a new independent review panel to evaluate requests from researchers who want to access data from industry-sponsored clinical trials.
19 January 2016
Goldman Sachs, Wellcome Trust and Greystar launch new student housing company Goldman Sachs, Wellcome Trust and Greystar have formed a joint venture to launch a new student housing company, Vero Group, it was announced today.
Alternatives to antibiotics not a short-term solution to drug-resistant infections A handful of alternatives to antibiotics – such as treatments and preventative measures based on live microorganisms or ‘probiotics’ – have the potential to combat bacterial infections in the next decade, but they are unlikely to replace traditional antibiotics. 13 January 2016
Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888